Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sierra Oncology, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sierra Oncology, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Sierra Oncology, Inc. since 2005.
The reporting company's ticker symbol is SRRA. The reporting company's CIK number is 1290149.
The total value of stock buying since 2005 is $25,321,140.
The total value of stock sales since 2005 is $388,902.
The total value of stock option exercises since 2005 is $19,913.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-10||Allen Andrew R (Director)||Buy||66,000||1.64||108,240|
|2017-03-08||You Angie (Chief Bus. & Strat. Officer)||Buy||30,000||1.43||42,900|
|2017-02-14||Topper James N (Director)||Buy||5,925,926||1.35||8,000,000|
|2016-03-22||Chapman Wendy (SVP Clinical Operations)||Sale||3,000||7.01||21,024|
|2016-03-22||Chapman Wendy (SVP Clinical Operations)||Option Ex||3,000||.97||2,907|
|2016-01-22||Rodigueza Wendi (Chief Scientific Officer)||Sale||1,000||9.66||9,660|
|2016-01-22||Chapman Wendy (SVP Clinical Operations)||Sale||5,000||9.39||46,975|
|2016-01-22||Chapman Wendy (SVP Clinical Operations)||Option Ex||5,000||.97||4,845|
|2016-01-21||Rodigueza Wendi (Chief Scientific Officer)||Sale||1,000||10.32||10,323|
|2016-01-20||Rodigueza Wendi (Chief Scientific Officer)||Sale||1,000||9.59||9,590|
|2016-01-15||Glover Nicholas (CEO and President)||Sale||5,000||10.04||50,225|
|2016-01-15||Glover Nicholas (CEO and President)||Option Ex||5,000||.97||4,845|
|2016-01-12||Lovejoy Chandra D (SVP of Reg. Affairs & Quality)||Sale||20,973||11.50||241,105|
|2016-01-12||Lovejoy Chandra D (SVP of Reg. Affairs & Quality)||Option Ex||7,551||.97||7,316|
|2015-07-21||Orbimed Private Investments V, Lp (Director)||Buy||175,000||17.00||2,975,000|
|2015-07-21||Vivo Ventures Vii Affiliates Fund, L.p. (Other)||Buy||220,000||17.00||3,740,000|
|2015-07-21||Cha Albert (Director)||Buy||220,000||17.00||3,740,000|
|2015-07-21||Thompson Peter A. (Director)||Buy||175,000||17.00||2,975,000|
|2015-07-21||Topper James N (Director)||Buy||220,000||17.00||3,740,000|
Insider trading activities including stock purchases, stock sales, and option exercises of SRRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sierra Oncology, Inc. (symbol SRRA, CIK number 1290149) see the Securities and Exchange Commission (SEC) website.